Trial Profile
Einfluss Selektiver I(f)-Blockade Auf Orthostase-Toleranz Und Sympathikusaktivitaet Bei Gesunden.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Metoprolol (Primary) ; Reboxetine
- Indications Tachycardia
- Focus Therapeutic Use
- 16 Nov 2011 Actual end date (Aug 2011) added as reported by European Clinical Trials Database.
- 16 Nov 2011 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 25 Mar 2009 New trial record